NeuroSci

NeuroSci is an online-only open access journal published by MDPI in Basel, covering neurology and neuroscience from laboratory work to clinical case series, with every paper under a Creative Commons Attribution licence and no subscription edition. Its 2025 Journal Impact Factor is 1.9, against 2.4 over five years.《神经科学》（NeuroSci）是 MDPI 在巴塞尔出版的纯网络开放获取期刊，覆盖神经病学与神经科学，从实验室研究到临床病例系列都在其内，全部论文按知识共享署名许可发布，不设订阅版。2025 年影响因子为 1.9，五年影响因子 2.4。

The title began with a single volume in 2020 and now runs to a seventh in 2026, printed nowhere but posted continuously, so a paper is addressed by an article number rather than by a page range.刊物 2020 年以第 1 卷起步，到 2026 年已出至第 7 卷，不印纸本而按篇连续上线，文章凭文章编号定位，不用起止页码。

Scope

• The scope statement keeps to two fields. It names neurology and neuroscience and asks for original work that moves either of them forward, without cutting the territory into a list of subdisciplines.宗旨只落在两个领域上，点名神经病学与神经科学，征集能推动其中任一领域前进的原创研究，不把学科切成一份分支清单。
• Neurodegeneration supplies the largest block of papers. Parkinson's disease alone brings rotenone models of its central and peripheral features, a post hoc study of rapid eye movement sleep without atonia at home and a meta-analysis of physiotherapy for balance and gait.神经退行性病变占最大一块，单是帕金森病就有复制其中枢与外周特征的鱼藤酮模型、居家记录快速眼动期肌张力缺失的事后分析，以及评估物理治疗对平衡与步态效果的荟萃分析。
• Multiple sclerosis runs through every volume, from a first-volume audit of haematological changes under teriflunomide and dimethyl fumarate to a meta-analysis of slowly expanding lesions and work on serum iron against depression, fatigue and imaging activity.多发性硬化贯穿各卷，第 1 卷就考察特立氟胺与富马酸二甲酯治疗下的血液学变化，近年则有缓慢扩大病灶的荟萃分析，以及血清铁与抑郁、疲劳和影像活动度关系的研究。
• Alzheimer's disease and mild cognitive impairment carry similar weight, with United States mortality trends during the pandemic, inflammatory mediators in the APP/PS1 mouse, a systematic review of long-term sedative use and a review of drug treatment for mild cognitive impairment.阿尔茨海默病与轻度认知障碍分量相当，相关论文有疫情期间的美国死亡率走势、APP/PS1 小鼠的炎症介质、长期服用镇静催眠药与患病风险的系统综述，以及轻度认知障碍药物治疗的综述。
• Epilepsy and the neonatal ward meet in a retrospective cohort on levetiracetam for neonatal seizures, an analysis of amplitude-integrated EEG for short-term outcome in infants with congenital heart disease and a mouse study of early-life seizures.癫痫与新生儿病房在一处交汇，有左乙拉西坦治疗新生儿惊厥的回顾性队列、用振幅整合脑电图预测先天性心脏病婴儿近期神经结局的分析，还有幼年期惊厥的小鼠实验。
• Stroke work reaches into intensive care, with a review of ischaemic and haemorrhagic management in the unit, a nationwide cohort on thrombolysis in patients carrying cerebral cavernous malformations and a scoping review of vagus nerve stimulation after stroke.卒中研究延伸到重症监护，有病房内缺血性与出血性卒中处理的综述，有脑海绵状血管瘤患者溶栓安全性的全国队列，还有卒中后迷走神经刺激的范围综述。
• Imaging papers favour the difficult case, among them post-mortem 7.0-tesla magnetic resonance imaging of the hippocampus in progressive supranuclear palsy and a comparison of diagnosis age with clinical and MRI findings in multiple sclerosis.影像学稿件偏爱疑难病例，其中包括进行性核上性麻痹患者死后海马的 7.0 特斯拉磁共振成像，也有多发性硬化发病年龄与临床及影像表现关系的分析。
• Neurophysiology and engineering share space, where a test-retest study of quadriceps corticospinal excitability under transcranial magnetic stimulation sits beside filter-bank work on fatigue in a wearable EEG interface and event-related potential evidence on numerosity in working memory.神经生理与工程学共用版面，股四头肌经颅磁刺激皮层兴奋性的重测信度研究，与可穿戴脑电接口中疲劳监测的滤波器组方法、工作记忆中数量加工的事件相关电位证据并列。
• Rehabilitation is a standing interest, from exercise-based telerehabilitation for frail older adults and multimodal treatment of persistent post-concussion syndrome to neurofeedback trials in competitive golfers and a systematic review of neurofeedback in football.康复是长期主题，有面向衰弱老人的运动远程康复、持续脑震荡后综合征的多模式治疗，也有竞技高尔夫球手的神经反馈试验和足球领域神经反馈的系统综述。
• Stimulation therapies are spread across diseases rather than gathered in one section, covering responsive neurostimulation after viral brain infection, spinal cord stimulation leads placed during spine surgery and an umbrella review of targeted drugs in generalised myasthenia gravis.刺激疗法散见于各种疾病而非集中在一个栏目，有病毒性脑炎病史患者的反应性神经刺激、脊柱手术同期放置脊髓刺激电极的经验，也有全身型重症肌无力靶向治疗的伞形综述。
• Cognitive neuroscience keeps a footing in music and development, with a statistical reading of individuality in jazz improvisation, functional networks in developmental dyslexia and an account of interoception routed through the autonomic nervous system.认知神经科学在音乐与发展领域占住一角，有对爵士即兴中个体性的统计分析、发展性阅读障碍的功能网络研究，以及经自主神经系统讨论内感受的论文。
• Headache and general neurology arrive through a pilot study on personality traits and the response to anti-CGRP therapy, a comparison of atypical positional vertigo with the central form and age-specific antibiograms for bacterial meningitis.头痛与一般神经病学另有三处入口，人格特质与抗降钙素基因相关肽治疗反应的初步研究，非典型位置性眩晕与中枢性位置性眩晕的鉴别，以及细菌性脑膜炎病原体的年龄别药敏谱。
• Neurosurgery and neuro-oncology contribute case-based work, among it the prognostic weight of PART in glioblastoma, a feasibility study of a new neurocognitive battery in temporal lobe glioma and a pseudoaneurysm after depressed skull fracture.神经外科与神经肿瘤贡献病例类稿件，其中包括 PART 在胶质母细胞瘤中的预后意义、颞叶胶质瘤患者试用新型神经认知测验的可行性研究，以及凹陷性颅骨骨折后大脑中动脉假性动脉瘤的个案。
• Reviews carry a large share of the list. Narrative reviews, scoping reviews and meta-analyses make up roughly a fifth of the 416 registered items, and the journal also prints essays on research ethics in traumatic brain injury and on professionalism as neurosurgery turns to robots.综述在目录里占很大一块，叙述性综述、范围综述与荟萃分析合计约占 416 条登记条目的五分之一，刊物还刊登创伤性脑损伤研究伦理的讨论，以及神经外科转向机器人过程中的职业规范文章。

History

• The first volume is dated 2020 and came out in two issues, opened by a short editorial, “Welcome to the New Open Access NeuroSci”, which announced an open access journal for neurology and neuroscience.第 1 卷标注 2020 年，分两期刊行，开卷是一篇简短社论，题为“Welcome to the New Open Access NeuroSci”，宣告一本面向神经病学与神经科学的开放获取刊物成立。^[1]
• The second issue of that year carried another editorial on systems biology in neuroscience, arguing that data should be shared and that the datasets behind a published result should be cited like any other source.同年第 2 期另有一篇社论，讨论系统生物学在神经科学中的位置，主张共享数据，并为已发表结果背后的数据集标注引用。^[2]
• Volume numbers have followed the calendar from the start, so volume one is 2020, volume five is 2024 and volume seven is 2026, and a citation can be dated from the volume alone.卷号自创刊起就与日历年对应，第 1 卷为 2020 年，第 5 卷为 2024 年，第 7 卷为 2026 年，读者凭卷号即可推知年份。
• Four issues a volume became the pattern from volume two and held through volume six, while the opening year carried two because the title started partway through 2020.自第 2 卷起每卷固定 4 期，这一节奏延续到第 6 卷，首年因刊物在 2020 年年中启动，只出了 2 期。
• Volume seven breaks with that rhythm by running to six issues in 2026, and the registered issue numbers bear it out, the sixth already open while the fifth was still taking papers.第 7 卷打破旧例，2026 年排到 6 期，登记在案的期号也印证这一点，第 5 期还在收稿时第 6 期已经开张。
• Output climbed unevenly. Eleven items were registered in 2020, 35 in 2021 and 51 in 2022, then 25 in 2023, 49 in 2024 and 133 in 2025.载文量起伏上升，2020 年登记 11 篇，2021 年 35 篇，2022 年 51 篇，2023 年回落至 25 篇，2024 年 49 篇，2025 年增至 133 篇。
• Papers are addressed by an article number inside the DOI, in which the volume and the issue each take two digits after the journal's short name, and no page range is ever issued.论文靠 DOI 里的文章编号定位，刊名缩写之后依次是两位卷号、两位期号和文章序号，全刊不发起止页码。
• PubMed coverage begins with volume three, number one, in 2022, and the full text of each paper also goes to PubMed Central, where most readers outside the publisher's platform meet the journal.美国国家医学图书馆的收录从 2022 年第 3 卷第 1 期开始，每篇全文同时进入 PubMed Central，出版方平台之外的读者多在那一处读到本刊。
• The Directory of Open Access Journals registered the title in May 2021 and records 2020 as its first open access year, with a Creative Commons Attribution licence and no embargo.开放获取期刊目录于 2021 年 5 月登记本刊，把 2020 年记为首个开放获取年度，许可为知识共享署名，不设时滞。
• Web of Science keeps the journal in the Emerging Sources Citation Index rather than the Science Citation Index Expanded, and the Journal Impact Factor has moved from 1.6 in 2023 to 2.0 in 2024 and 1.9 in 2025.Web of Science 把本刊收入新兴来源引文索引，未进科学引文索引扩展版，影响因子从 2023 年的 1.6 升到 2024 年的 2.0，2025 年为 1.9。
• The 2025 release places the title in two categories at once, 201st of 296 in clinical neurology and 266th of 330 in neurosciences, with a composite percentile of 32.3 and a citation indicator of 0.5.2025 年度榜单把本刊同时列入两个类目，临床神经病学 296 种中列第 201 位，神经科学 330 种中列第 266 位，综合百分位 32.3，期刊引文指标 0.5。
• The citation base is still small and young, 469 citations in the window and a cited half-life of 3.1 years, both typical of a list that is seven years old.引文基数仍小且年轻，统计窗口内被引 469 次，引用半衰期 3.1 年，两项都合乎一份只有七年历史的刊物。
• The publisher is MDPI AG of Basel, the catalogue imprint reads Basel from 2020, and there is no print edition, one electronic number, 2673-4087, standing for the whole title.出版方为巴塞尔的 MDPI AG，图书馆目录把 2020 年起的出版地记为巴塞尔，刊物没有纸本版，全刊只用一个电子刊号 2673-4087。
• Long-term archiving is contracted to CLOCKSS with a copy lodged at the Swiss National Library, and the article processing charge is listed at 1,000 Swiss francs, paid once a paper is accepted.长期存档交由 CLOCKSS 承担，另在瑞士国家图书馆存一份，文章处理费列为 1000 瑞士法郎，论文录用后支付。

Editors

• François Ichas, at the Institut des Maladies Neurodégénératives of CNRS and the University of Bordeaux, is named editor-in-chief in the journal profile carried through 2026.主编（François Ichas）任职于法国国家科研中心与波尔多大学的神经退行性疾病研究所，2026 年刊物各处的介绍均以此署名。
• The journal site carries an editorial board page of its own, and enquiries go to the editorial office through the publisher's Basel headquarters rather than a personal address.刊物网站另设编委页面，编辑部事务经出版方位于巴塞尔的机构转达，不对外公布个人邮箱。
• Special issues are run by guest editors drawn from the field, each named with an affiliation on the issue's own page, and their calls for papers state a closing date.特刊由学界客座编辑主持，每位都在专辑页面上连同所在单位一并列出，征稿启事则写明截止日期。
• Review is single anonymous. Registration with the Directory of Open Access Journals records that model and points readers to the editorial procedure section of the instructions for authors.评审为单向匿名，刊物在开放获取期刊目录的登记把模式记为单盲，并把读者引向作者须知中的编辑流程一节。
• Referee names stay closed and reports are never printed beside the article, so the public record shows who wrote a paper and when it was handled, not who judged it.评审人姓名不公开，评审意见也不随文刊出，公开记录里能看到作者与处理时间，看不到评议者是谁。
• Speed is advertised plainly, 23.3 days to a first decision and 4.7 days from acceptance to publication, figures printed beside the impact factor in the profile current through 2026.审稿速度写得直白，首次决定 23.3 天，录用到上线 4.7 天，两个数字与影响因子并排印在 2026 年的刊物介绍里。
• Length is not capped. The same profile says a paper may run long but must carry complete experimental detail so that the work can be repeated by others.篇幅不设上限，同一份介绍写明论文可以写得长，但须给出完整实验细节，以便他人重复这项工作。
• Synthesis carries real weight. Of 416 items registered with Crossref, 70 carry the word review in the title, 21 are systematic reviews and 13 are meta-analyses.综合类稿件分量不轻，登记在 Crossref 的 416 条记录中，标题含综述字样的 70 条，系统综述 21 条，荟萃分析 13 条。
• Case material is accepted but rationed, ten titles among the same records opening with the words case report, and five study protocols are printed ahead of the results they describe.病例类稿件收而有限，同一批记录里以个案报告开题的 10 条，另有 5 篇研究方案，先于其描述的结果刊出。
• Judgement stays close to the clinic without abandoning the bench, so a five-case series on Creutzfeldt-Jakob disease, a mouse model of hippocampal depolarisation block and a national mortality analysis can share a volume.编辑判断贴近临床又不放弃实验室，克雅氏病五例系列、海马去极化阻滞的小鼠模型与全国死亡数据分析可以同处一卷。
• Special issues are gathered and then introduced by an editorial, and a themed collection on cognitive impairment in multiple sclerosis has run across more than one volume.特刊编成后另配一篇编者按，多发性硬化认知损害主题的合辑已跨卷收录。